Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

August 1, 2022

Conditions
STEMI - ST Elevation Myocardial InfarctionMicrovascular Coronary Artery Disease
Interventions
PROCEDURE

pressure-temperature sensor guidewire-based measurement

"In brief, a 6-F angioplasty guiding catheter without side-holes will be used first used to engage the left main coronary artery. A pressure-temperature sensor guidewire ( PressureWire™ X Guidewire) will be used for physiology measurements including IMR measurements.~Pressure measurement from the wire was first equalized with that of the guiding catheter. Then the pressure sensor will be positioned two-thirds of the way down the LAD artery. Intracoronary nitroglycerin will be administered (100 to 200 μg). Hyperemia will be induced with adenosine intracoronary injections."

Trial Locations (1)

LT-50161

Ali Aldujeli, Kaunas

All Listed Sponsors
collaborator

Università degli Studi di Brescia

OTHER

collaborator

Kreiskrankenhaus Rotenburg

UNKNOWN

lead

Lithuanian University of Health Sciences

OTHER

NCT05406297 - Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients | Biotech Hunter | Biotech Hunter